THOMAS WESTBROOK to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications THOMAS WESTBROOK has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.100
-
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. Breast Cancer Res. 2014 Sep 11; 16(5):430.
Score: 0.100